Glenmark Pharmaceuticals Ltd. Industry : (Pharmaceuticals)

Quick Glance
Listed on BSE and NSE
  • Market Cap 17,967Crores
  • Book Value 183
  • Face Value 1
  • Current Price 636.75
  • % Change -0.69
  • 52 week H/L 712/ 484
  • Stock P/E 22.35
  • Dividend Yield 0 %

Stock vs. Index

GlenmarkPhar
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
18.82 -28.24 -22.55 -20.97 10.17

ROCE Vs RONW

ROCE
RONW

Price History


  • Start Date :
  • End Date :

You can view historic prices (Open,High,Low,Close) of the company for the range of days


Shareholding Pattern

collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Mar 17 Jun 17 Sep 17 Dec 17 Mar 18 Jun 18 Sep 18 Dec 18
Sales 2065.09 1547.78 1659.81 1556.55 1667.75 1618.41 1679.72 1632.04
Other Income -50.25 42.59 56.30 37.23 44.30 173.65 226.30 -84.64
Operating Profit 672.10 352.94 397.46 266.80 330.31 410.30 391.81 349.36
Interest 49.72 45.74 47.44 47.00 50.72 55.17 60.85 55.18
Depreciation 27.32 29.94 28.89 29.55 29.82 33.42 26.92 25.70
Taxation -48.70 49.01 49.55 33.36 72.56 97.97 172.95 14.41
Net Profit / Loss 357.06 270.84 327.88 194.12 221.51 397.39 747.56 195.87

Annual Results

(All figures In Rs. Cr.) Mar 10 Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18
Sales 1022.78 1154.63 1564.67 1949.30 2300.90 5085.60 6203.08 8095.50 6431.88
Other Income 8.32 30.39 55.10 116.25 67.13 84.94 117.38 148.24 180.42
Operating Profit 164.13 277.49 310.98 332.44 495.97 1464.99 1765.18 2898.64 1347.51
Interest 30.16 36.08 60.87 43.69 30.98 30.19 36.22 152.60 190.90
Depreciation 21.28 20.99 21.11 25.04 30.20 119.46 99.81 104.93 118.20
Taxation -7.45 38.63 18.80 -6.15 68.10 224.02 262.26 412.29 204.48
Net Profit / Loss 128.46 212.18 265.30 386.11 433.82 1007.53 1484.27 2140.61 1014.35

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM 3.51% -26.40%
1 Years -15.28% -11.00%
2 Years -38.09% -38.09%
3 Years -32.01% -36.16%
4 Years -29.95% -34.83%
5 Years -21.24% -17.57%

Investor Returns

Type Ratio / % Date
Dividend
200.00
19 Sep 2018
Bonus
1:1
04 Mar 2005
Split
2:1
10 Sep 2007

Announcements

Date Title
Mar 15, 2019 Glenmark gets ANDA nod for Clindamycin and Benzoyl Peroxide Gel
Mar 15, 2019 Glenmark Pharma receives ANDA approval
Mar 15, 2019 Glenmark Pharma - Press Release
Mar 15, 2019 Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 18, 2019 Glenmark Pharma gets final approval for Clobetasol Propionate Foam
collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
464.10
-1.57%
111,353.14
678.80 / 375.40
158.80
51.52
Piramal Enterprises Ltd.
2,574.05
-0.98%
47,372.86
3,302.55 / 1,796.75
1,436.98
9.25
Dr. Reddy's Laboratories Ltd.
2,761.00
0.40%
45,850.81
2,875.00 / 1,888.00
757.03
48.43
Aurobindo Pharma Ltd.
775.40
0.69%
45,431.28
830.00 / 527.05
199.36
18.75
Divi's Laboratories Ltd.
1,704.00
2.05%
45,235.85
1,728.35 / 994.95
223.18
51.58
Cipla Ltd.
527.30
0.09%
42,484.51
678.00 / 483.75
176.61
30.12
Biocon Ltd.
613.00
-0.49%
36,780.00
718.35 / 543.80
86.33
98.77
Cadila Healthcare Ltd.
334.00
0.33%
34,193.00
432.40 / 306.35
85.42
19.26
Lupin Ltd.
729.10
-1.94%
32,990.55
986.00 / 723.55
300.06
131.30
Torrent Pharmaceuticals Ltd.
1,861.85
-0.54%
31,506.73
1,960.00 / 1,223.75
273.14
46.46